CN Stock MarketDetailed Quotes

Zhejiang Xianju Pharmaceutical (002332)

Watchlist
  • 9.12
  • +0.08+0.88%
Market Closed Apr 17 15:00 CST
9.02BMarket Cap32.92P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zhejiang Xianju Pharmaceutical (002332) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-12.71%2.83B
-12.56%1.87B
-2.86%1.01B
-2.98%4B
-0.01%3.24B
0.93%2.14B
8.42%1.04B
-5.85%4.12B
-6.24%3.24B
-4.93%2.12B
Operating revenue
-12.71%2.83B
-12.56%1.87B
-2.86%1.01B
-2.98%4B
-0.01%3.24B
0.93%2.14B
8.42%1.04B
-5.85%4.12B
-6.24%3.24B
-4.93%2.12B
Other operating revenue
----
1.14%12.31M
----
-51.83%21.17M
----
-14.09%12.17M
----
104.30%43.96M
----
11.33%14.17M
Total operating cost
-8.62%2.38B
-10.95%1.54B
-3.27%843.84M
-5.14%3.31B
-2.84%2.61B
-0.70%1.73B
9.84%872.35M
-4.22%3.49B
-5.18%2.68B
-5.21%1.74B
Operating cost
-27.48%1.07B
-28.67%688.61M
-3.41%450.03M
-12.47%1.7B
-6.95%1.47B
-5.67%965.4M
2.14%465.93M
6.02%1.94B
7.38%1.58B
9.81%1.02B
Operating tax surcharges
15.24%27.67M
13.89%18.92M
21.81%6.81M
-4.48%35.21M
-3.76%24.01M
-2.09%16.62M
3.94%5.59M
-4.35%36.87M
-10.60%24.95M
-9.93%16.97M
Operating expense
15.86%841.42M
12.22%547.77M
-2.94%248.29M
4.42%1.03B
-0.09%726.21M
6.28%488.13M
15.65%255.8M
-21.60%989.98M
-27.39%726.84M
-29.63%459.3M
Administration expense
12.57%254.56M
3.54%164.43M
-14.20%70.69M
10.16%309.79M
-2.77%226.13M
0.04%158.81M
15.19%82.39M
4.31%281.23M
16.77%232.56M
10.19%158.75M
Financial expense
77.46%-5.26M
79.30%-4.89M
53.16%-2.74M
-53.62%-34.28M
-19.01%-23.33M
-152.77%-23.6M
-315.93%-5.86M
16.45%-22.32M
-0.07%-19.6M
-45.10%-9.33M
-Interest expense (Financial expense)
132.41%3.22M
74.55%1.64M
-75.12%148.33K
-6.94%3.13M
-46.08%1.39M
-46.37%937.73K
-31.17%596.19K
-46.47%3.37M
-64.95%2.57M
-71.38%1.75M
-Interest Income (Financial expense)
48.10%-12.69M
50.88%-9.37M
50.14%-3.65M
22.99%-29.48M
14.09%-24.44M
-2.61%-19.08M
-2.08%-7.31M
-40.79%-38.28M
-215.12%-28.45M
-203.06%-18.59M
Research and development
7.41%198.42M
0.78%125.93M
3.31%70.77M
1.60%265.17M
32.46%184.73M
33.79%124.96M
65.73%68.51M
-2.16%261M
-7.54%139.46M
-3.79%93.4M
Credit Impairment Loss
24.04%-5.85M
5.88%-4.92M
32.29%-4.06M
-327.20%-11.45M
-13.44%-7.7M
54.29%-5.22M
31.93%-5.99M
154.33%5.04M
49.88%-6.78M
7.96%-11.43M
Asset Impairment Loss
-2.74%-24.22M
-0.06%-24.24M
----
-52.36%-43.51M
14.27%-23.57M
12.00%-24.22M
----
11.21%-28.56M
-69.24%-27.49M
-48.01%-27.52M
Other net revenue
31,284.93%20.33M
917.44%18.6M
-131.19%-5.74M
-192.86%-12M
100.65%64.77K
108.26%1.83M
291.21%18.41M
-90.94%12.92M
-128.90%-9.92M
-197.43%-22.13M
Invest income
-196.07%-12.25M
-153.74%-9.62M
-130.97%-5.78M
9.34%-8.14M
11.97%12.75M
107.22%17.9M
1,677.20%18.68M
-118.18%-8.97M
-70.86%11.39M
-75.58%8.64M
-Including: Investment income associates
-1,196.02%-12.06M
-324.00%-9.44M
-215.79%-5.78M
-173.66%-21.76M
-108.17%-930.85K
-51.21%4.21M
521.81%5M
-105.35%-7.95M
112.29%11.39M
108.48%8.64M
Asset deal income
6,432.33%46.27M
74,950.13%46.21M
-97.21%1.8K
119.18%283.09K
57.18%-730.69K
103.54%61.58K
104.33%64.29K
-101.61%-1.48M
-3,866.88%-1.71M
-3,936.07%-1.74M
Other revenue
-15.21%16.37M
-16.21%11.15M
-27.53%4.1M
8.37%50.81M
31.55%19.31M
34.16%13.31M
206.70%5.66M
9.05%46.89M
-30.44%14.68M
-37.99%9.92M
Operating profit
-26.42%464.1M
-15.22%347.04M
-13.79%158.62M
4.91%678.21M
15.71%630.73M
15.79%409.36M
19.89%183.98M
-26.42%646.46M
-17.19%545.1M
-14.31%353.52M
Add:Non operating Income
-86.90%226.49K
-78.53%365.72K
-58.09%514.96K
570.83%28.96M
-51.30%1.73M
-22.41%1.7M
9.58%1.23M
191.35%4.32M
-36.69%3.55M
3,381.62%2.19M
Less:Non operating expense
47.05%6.98M
3.55%4.08M
-59.35%1.25M
2,196.09%208.84M
-11.53%4.75M
-5.26%3.94M
243.30%3.08M
11.10%9.1M
-43.40%5.36M
-50.46%4.16M
Total profit
-27.14%457.35M
-15.67%343.33M
-13.31%157.88M
-22.34%498.33M
15.54%627.71M
15.80%407.12M
18.51%182.13M
-26.40%641.68M
-16.97%543.29M
-13.03%351.56M
Less:Income tax cost
-27.68%61.48M
-20.55%47.23M
-23.02%19.72M
23.68%98.4M
19.17%85.01M
17.50%59.45M
5.05%25.61M
-36.09%79.56M
-41.35%71.34M
-37.19%50.59M
Net profit
-27.06%395.87M
-14.84%296.1M
-11.73%138.16M
-28.85%399.92M
14.99%542.7M
15.52%347.68M
21.05%156.52M
-24.79%562.12M
-11.41%471.95M
-7.01%300.97M
Net profit from continuing operation
-27.06%395.87M
-14.84%296.1M
-11.73%138.16M
-28.85%399.92M
14.99%542.7M
15.52%347.68M
21.05%156.52M
-24.79%562.12M
-11.41%471.95M
-7.01%300.97M
Less:Minority Profit
-186.40%-10.81M
-253.04%-12.17M
-207.89%-5.82M
384.37%2.74M
3,475.78%12.52M
1,044.14%7.95M
241.42%5.39M
52.08%-965.01K
-90.05%350.04K
88.67%-842.4K
Net profit of parent company owners
-23.29%406.68M
-9.26%308.27M
-4.72%143.98M
-29.46%397.18M
12.42%530.18M
12.56%339.72M
13.53%151.12M
-24.86%563.08M
-10.89%471.6M
-8.84%301.81M
Earning per share
Basic earning per share
-23.30%0.4111
-9.26%0.3116
-4.71%0.1456
-29.82%0.4
12.44%0.536
10.77%0.3434
17.54%0.1528
-24.76%0.57
-10.90%0.4767
-6.06%0.31
Diluted earning per share
-23.30%0.4111
-9.26%0.3116
-4.71%0.1456
-29.82%0.4
12.44%0.536
10.77%0.3434
17.54%0.1528
-24.76%0.57
-10.90%0.4767
-6.06%0.31
Other composite income
2,652.01%137.74M
557.58%149.11M
253.19%46.22M
-242.94%-64.14M
-121.30%-5.4M
-146.31%-32.59M
-308.97%-30.17M
106.59%44.87M
205.70%25.34M
406.28%70.36M
Other composite income of parent company owners
2,652.01%137.74M
557.58%149.11M
253.19%46.22M
-242.94%-64.14M
-121.30%-5.4M
-146.31%-32.59M
-308.97%-30.17M
106.59%44.87M
205.70%25.34M
406.28%70.36M
Total composite income
-0.69%533.61M
41.29%445.2M
45.94%184.38M
-44.68%335.79M
8.05%537.3M
-15.14%315.09M
-12.10%126.34M
-21.08%606.99M
-2.26%497.29M
23.49%371.32M
Total composite income of parent company owners
3.74%544.43M
48.92%457.38M
57.26%190.21M
-45.22%333.04M
5.60%524.78M
-17.47%307.14M
-18.03%120.95M
-21.16%607.95M
-1.64%496.94M
20.79%372.17M
Total composite income of minority owners
-186.40%-10.81M
-253.04%-12.17M
-207.89%-5.82M
384.37%2.74M
3,475.78%12.52M
1,044.14%7.95M
241.42%5.39M
52.08%-965.01K
-90.05%350.04K
88.67%-842.4K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -12.71%2.83B-12.56%1.87B-2.86%1.01B-2.98%4B-0.01%3.24B0.93%2.14B8.42%1.04B-5.85%4.12B-6.24%3.24B-4.93%2.12B
Operating revenue -12.71%2.83B-12.56%1.87B-2.86%1.01B-2.98%4B-0.01%3.24B0.93%2.14B8.42%1.04B-5.85%4.12B-6.24%3.24B-4.93%2.12B
Other operating revenue ----1.14%12.31M-----51.83%21.17M-----14.09%12.17M----104.30%43.96M----11.33%14.17M
Total operating cost -8.62%2.38B-10.95%1.54B-3.27%843.84M-5.14%3.31B-2.84%2.61B-0.70%1.73B9.84%872.35M-4.22%3.49B-5.18%2.68B-5.21%1.74B
Operating cost -27.48%1.07B-28.67%688.61M-3.41%450.03M-12.47%1.7B-6.95%1.47B-5.67%965.4M2.14%465.93M6.02%1.94B7.38%1.58B9.81%1.02B
Operating tax surcharges 15.24%27.67M13.89%18.92M21.81%6.81M-4.48%35.21M-3.76%24.01M-2.09%16.62M3.94%5.59M-4.35%36.87M-10.60%24.95M-9.93%16.97M
Operating expense 15.86%841.42M12.22%547.77M-2.94%248.29M4.42%1.03B-0.09%726.21M6.28%488.13M15.65%255.8M-21.60%989.98M-27.39%726.84M-29.63%459.3M
Administration expense 12.57%254.56M3.54%164.43M-14.20%70.69M10.16%309.79M-2.77%226.13M0.04%158.81M15.19%82.39M4.31%281.23M16.77%232.56M10.19%158.75M
Financial expense 77.46%-5.26M79.30%-4.89M53.16%-2.74M-53.62%-34.28M-19.01%-23.33M-152.77%-23.6M-315.93%-5.86M16.45%-22.32M-0.07%-19.6M-45.10%-9.33M
-Interest expense (Financial expense) 132.41%3.22M74.55%1.64M-75.12%148.33K-6.94%3.13M-46.08%1.39M-46.37%937.73K-31.17%596.19K-46.47%3.37M-64.95%2.57M-71.38%1.75M
-Interest Income (Financial expense) 48.10%-12.69M50.88%-9.37M50.14%-3.65M22.99%-29.48M14.09%-24.44M-2.61%-19.08M-2.08%-7.31M-40.79%-38.28M-215.12%-28.45M-203.06%-18.59M
Research and development 7.41%198.42M0.78%125.93M3.31%70.77M1.60%265.17M32.46%184.73M33.79%124.96M65.73%68.51M-2.16%261M-7.54%139.46M-3.79%93.4M
Credit Impairment Loss 24.04%-5.85M5.88%-4.92M32.29%-4.06M-327.20%-11.45M-13.44%-7.7M54.29%-5.22M31.93%-5.99M154.33%5.04M49.88%-6.78M7.96%-11.43M
Asset Impairment Loss -2.74%-24.22M-0.06%-24.24M-----52.36%-43.51M14.27%-23.57M12.00%-24.22M----11.21%-28.56M-69.24%-27.49M-48.01%-27.52M
Other net revenue 31,284.93%20.33M917.44%18.6M-131.19%-5.74M-192.86%-12M100.65%64.77K108.26%1.83M291.21%18.41M-90.94%12.92M-128.90%-9.92M-197.43%-22.13M
Invest income -196.07%-12.25M-153.74%-9.62M-130.97%-5.78M9.34%-8.14M11.97%12.75M107.22%17.9M1,677.20%18.68M-118.18%-8.97M-70.86%11.39M-75.58%8.64M
-Including: Investment income associates -1,196.02%-12.06M-324.00%-9.44M-215.79%-5.78M-173.66%-21.76M-108.17%-930.85K-51.21%4.21M521.81%5M-105.35%-7.95M112.29%11.39M108.48%8.64M
Asset deal income 6,432.33%46.27M74,950.13%46.21M-97.21%1.8K119.18%283.09K57.18%-730.69K103.54%61.58K104.33%64.29K-101.61%-1.48M-3,866.88%-1.71M-3,936.07%-1.74M
Other revenue -15.21%16.37M-16.21%11.15M-27.53%4.1M8.37%50.81M31.55%19.31M34.16%13.31M206.70%5.66M9.05%46.89M-30.44%14.68M-37.99%9.92M
Operating profit -26.42%464.1M-15.22%347.04M-13.79%158.62M4.91%678.21M15.71%630.73M15.79%409.36M19.89%183.98M-26.42%646.46M-17.19%545.1M-14.31%353.52M
Add:Non operating Income -86.90%226.49K-78.53%365.72K-58.09%514.96K570.83%28.96M-51.30%1.73M-22.41%1.7M9.58%1.23M191.35%4.32M-36.69%3.55M3,381.62%2.19M
Less:Non operating expense 47.05%6.98M3.55%4.08M-59.35%1.25M2,196.09%208.84M-11.53%4.75M-5.26%3.94M243.30%3.08M11.10%9.1M-43.40%5.36M-50.46%4.16M
Total profit -27.14%457.35M-15.67%343.33M-13.31%157.88M-22.34%498.33M15.54%627.71M15.80%407.12M18.51%182.13M-26.40%641.68M-16.97%543.29M-13.03%351.56M
Less:Income tax cost -27.68%61.48M-20.55%47.23M-23.02%19.72M23.68%98.4M19.17%85.01M17.50%59.45M5.05%25.61M-36.09%79.56M-41.35%71.34M-37.19%50.59M
Net profit -27.06%395.87M-14.84%296.1M-11.73%138.16M-28.85%399.92M14.99%542.7M15.52%347.68M21.05%156.52M-24.79%562.12M-11.41%471.95M-7.01%300.97M
Net profit from continuing operation -27.06%395.87M-14.84%296.1M-11.73%138.16M-28.85%399.92M14.99%542.7M15.52%347.68M21.05%156.52M-24.79%562.12M-11.41%471.95M-7.01%300.97M
Less:Minority Profit -186.40%-10.81M-253.04%-12.17M-207.89%-5.82M384.37%2.74M3,475.78%12.52M1,044.14%7.95M241.42%5.39M52.08%-965.01K-90.05%350.04K88.67%-842.4K
Net profit of parent company owners -23.29%406.68M-9.26%308.27M-4.72%143.98M-29.46%397.18M12.42%530.18M12.56%339.72M13.53%151.12M-24.86%563.08M-10.89%471.6M-8.84%301.81M
Earning per share
Basic earning per share -23.30%0.4111-9.26%0.3116-4.71%0.1456-29.82%0.412.44%0.53610.77%0.343417.54%0.1528-24.76%0.57-10.90%0.4767-6.06%0.31
Diluted earning per share -23.30%0.4111-9.26%0.3116-4.71%0.1456-29.82%0.412.44%0.53610.77%0.343417.54%0.1528-24.76%0.57-10.90%0.4767-6.06%0.31
Other composite income 2,652.01%137.74M557.58%149.11M253.19%46.22M-242.94%-64.14M-121.30%-5.4M-146.31%-32.59M-308.97%-30.17M106.59%44.87M205.70%25.34M406.28%70.36M
Other composite income of parent company owners 2,652.01%137.74M557.58%149.11M253.19%46.22M-242.94%-64.14M-121.30%-5.4M-146.31%-32.59M-308.97%-30.17M106.59%44.87M205.70%25.34M406.28%70.36M
Total composite income -0.69%533.61M41.29%445.2M45.94%184.38M-44.68%335.79M8.05%537.3M-15.14%315.09M-12.10%126.34M-21.08%606.99M-2.26%497.29M23.49%371.32M
Total composite income of parent company owners 3.74%544.43M48.92%457.38M57.26%190.21M-45.22%333.04M5.60%524.78M-17.47%307.14M-18.03%120.95M-21.16%607.95M-1.64%496.94M20.79%372.17M
Total composite income of minority owners -186.40%-10.81M-253.04%-12.17M-207.89%-5.82M384.37%2.74M3,475.78%12.52M1,044.14%7.95M241.42%5.39M52.08%-965.01K-90.05%350.04K88.67%-842.4K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -